News

Graymark has acquired somniCare and somniTech (collectively, Somni) from Avastra. The Somni companies provide personalized sleep disorder testing and treatment as well as comprehensive care in sleep apnea

BioDelivery Sciences has revealed the issuance of US Patent No. 7,579,019, which will provide additional patent exclusivity for both Onsolis and BDSI’s Bema drug delivery technology platform, until

Morria Biopharmaceuticals has received written approval to initiate phase II clinical trial on its topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6. The double-blind, placebo-controlled study on 80 contact

Cadila Pharmaceuticals has introduced 5-in-1 wonder pill – Polycap in the domestic market, reported Times of India. The new pill is expected to be a combination of five

Cardium Therapeutics has revealed that all patients enrolled in the MATRIX clinical study have completed their initial 12-week evaluation period. The company plans to provide detailed safety and

Amgen has reported the top-line results of phase 3 study of Aranesp. Aranesp is for the treatment of anemia associated with CRF for patients on dialysis and patients

An EUA authorizes the use of unapproved medical products or unapproved uses of approved medical products during a declared public health emergency. “The FDA worked quickly with the

Medicago has received clearance from Health Canada to commence a phase I human clinical trial with its H5N1 Avian Influenza vaccine. Enrollment of volunteers is currently underway. According

Cellceutix has acquired the rights to the compound KM 732, which shows properties in the reduction of high blood pressure. Preliminary testing in rats revealed that test animals